RMD.AX - ResMed Inc.

ASX - ASX Delayed Price. Currency in AUD
22.07
+0.20 (+0.91%)
At close: 4:10PM AEDT
Stock chart is not supported by your current browser
Previous Close21.87
Open21.99
Bid23.40 x 0
Ask22.12 x 0
Day's Range21.90 - 22.17
52 Week Range12.65 - 22.30
Volume457,827
Avg. Volume1,170,865
Market Cap31.528B
Beta (3Y Monthly)0.41
PE Ratio (TTM)76.10
EPS (TTM)0.29
Earnings DateN/A
Forward Dividend & Yield0.23 (1.04%)
Ex-Dividend Date2019-11-06
1y Target Est12.43
  • Business Wire

    COPD Outcomes Improved Significantly When Patients and Doctors Used a Digital Health Tool, Propeller Health Study Finds

    Patients with chronic obstructive pulmonary disease (COPD) at Louisville’s JenCare Senior Medical Center, a ChenMed company, saw their health outcomes improve significantly when their primary care physicians (PCPs) encouraged using Propeller’s digital health tool to manage their COPD, reports new research by Propeller Health, JenCare, ChenMed, and the Center for Healthy Air, Water and Soil investigators published in JMIR Formative Research.

  • How Much is ResMed Inc.'s (NYSE:RMD) CEO Getting Paid?
    Simply Wall St.

    How Much is ResMed Inc.'s (NYSE:RMD) CEO Getting Paid?

    In 2013 Mick Farrell was appointed CEO of ResMed Inc. (NYSE:RMD). This report will, first, examine the CEO...

  • Propeller Health Users Can Now Access Pharmacy Services From CVS, Walmart, Kroger and Rite-Aid From Within the Propeller App
    Business Wire

    Propeller Health Users Can Now Access Pharmacy Services From CVS, Walmart, Kroger and Rite-Aid From Within the Propeller App

    With the expansion of the My Pharmacy feature, patients can use Propeller to refill prescriptions with five of the seven largest pharmaceutical providers in the U.S. Propeller Health, a leading digital health company dedicated to the management of asthma and chronic obstructive pulmonary disease (COPD), today announced that users are now able to access pharmacy services from CVS, Walmart, Kroger and Rite-Aid directly from the Propeller app. In January 2019, Propeller announced the launch of My Pharmacy, an in-app feature that allows users to manage their prescription refills for asthma and COPD and locate a nearby pharmacy from the Propeller app.

  • 4 Days To Buy ResMed Inc. (NYSE:RMD) Before The Ex-Dividend Date
    Simply Wall St.

    4 Days To Buy ResMed Inc. (NYSE:RMD) Before The Ex-Dividend Date

    ResMed Inc. (NYSE:RMD) is about to trade ex-dividend in the next 4 days. Ex-dividend means that investors that...

  • Should You Buy ResMed Inc. (NYSE:RMD) For Its Dividend?
    Simply Wall St.

    Should You Buy ResMed Inc. (NYSE:RMD) For Its Dividend?

    Today we'll take a closer look at ResMed Inc. (NYSE:RMD) from a dividend investor's perspective. Owning a strong...

  • Business Wire

    ResMed Announces Participation in the Credit Suisse 28th Annual Healthcare Conference

    ResMed today announced that Rob Douglas, chief operating officer, will present at the Credit Suisse 28th Annual Healthcare Conference on Tuesday, November 12, 2019, beginning at approximately 9:10 a.m.

  • Propeller Users Can Now Locate Their Lost Inhaler by “Ringing” Their Propeller Sensor From the App
    Business Wire

    Propeller Users Can Now Locate Their Lost Inhaler by “Ringing” Their Propeller Sensor From the App

    Starting today, Propeller users will be able to “ring” the sensor on a misplaced inhaler to make it easier to find, through an update to the Find My Inhaler feature in the Propeller app. Propeller is a digital health tool that helps people with asthma or COPD manage their breathing. Propeller sensors connect to patients’ existing inhalers and transmit data on medication use and health patterns to the Propeller app on patients’ smartphones.

  • Wall Street Jumps Friday
    GuruFocus.com

    Wall Street Jumps Friday

    Lear Corp reports financial results Continue reading...

  • S&P 500 Nears Record High As Technology, Transportation Lead Market
    Investor's Business Daily

    S&P 500 Nears Record High As Technology, Transportation Lead Market

    Stocks traded near session highs as the S&P; 500 today climbed close to a record peak and Alphabet neared a buy point.

  • Business Wire

    ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2020

    SAN DIEGO-- -- Year-over-year revenue grows 16%, non-GAAP operating profit up 22% Balanced growth across product portfolio and global markets Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com ResMed Inc. , a world-leading connected health company, today announced results for its quarter ended September 30, 2019. First Quarter 2020 Highlights ...

  • ResMed Introduces AirFit N30, World’s First Tube-Down Nasal Cradle CPAP Mask
    Business Wire

    ResMed Introduces AirFit N30, World’s First Tube-Down Nasal Cradle CPAP Mask

    ResMed (RMD) (RMD.AX) today introduced AirFit N30, the world’s first tube-down nasal cradle CPAP mask with a front-facing tube – a brand-new option for sleep apnea treatment. ResMed’s lightest mask yet, AirFit N30 features an adjustable elastic headgear, plus a nasal cradle cushion that sits under the nasal bridge, eliminating soreness in that area. Together, these innovations help make starting and staying on CPAP therapy easier than ever for more of the 936 million people worldwide living with sleep apnea.

  • Business Wire

    New Research Reveals Updated Patient Preferences on Digital Health Technology

    The survey highlights a reason for optimism that the markets for digital health technology will only continue to grow. The survey of a nationally representative sample of 3,000 Americans, conducted in partnership with Edelman Intelligence, revealed that the use of – and confidence in – remote digital health technology is widespread: 56% of those surveyed currently monitor their health with at least one digital data collection tool. Perhaps more surprising, remote digital health technology seems to have deepened people’s connection with their physicians rather than distanced them from one another.

  • Did Hedge Funds Drop The Ball On ResMed Inc. (RMD) ?
    Insider Monkey

    Did Hedge Funds Drop The Ball On ResMed Inc. (RMD) ?

    After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms' equity portfolios as of June 28. The results of that effort will be put on display in this article, as […]

  • Should You Consider ResMed Inc. (NYSE:RMD)?
    Simply Wall St.

    Should You Consider ResMed Inc. (NYSE:RMD)?

    Attractive stocks have exceptional fundamentals. In the case of ResMed Inc. (NYSE:RMD), there's has a a strong track...

  • GlobeNewswire

    Cerner and ResMed Join Forces to Connect Health Networks and the Home

    Cerner Corporation (CERN), a global health platform and innovation company, and ResMed (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced a new collaboration agreement to help providers make more informed treatment decisions, control costs and deliver seamless care across health systems to the home. To address this trend, Cerner designated ResMed’s Brightree Home Health and Hospice platform as its preferred solution in the space to integrate with its Cerner Millennium® electronic health record (EHR).

  • Business Wire

    ResMed to Report First Quarter Fiscal 2020 Earnings on October 24, 2019

    ResMed today announced it plans to release financial and operational results for the first quarter of fiscal year 2020 on Thursday, October 24, 2019, after the New York Stock Exchange closes.

  • Cloud-connected medical device company CEO responds to fears over hacking
    Yahoo Finance

    Cloud-connected medical device company CEO responds to fears over hacking

    With more than 10 million cloud-connected CPAP and other breathing devices on the market, CEO Mick Farrell completely understands why patients are wary about letting those devices send data to the cloud.

  • GuruFocus.com

    Resmed Inc (RMD) CEO Michael J. Farrell Sold $913,714 of Shares

    CEO of Resmed Inc (30-Year Financial, Insider Trades) Michael J. Farrell (insider trades) sold 6,651 shares of RMD on 09/09/2019 at an average price of $137.38 a share. Continue reading...

  • GuruFocus.com

    5 Companies Hit 52-Week Highs

    As of late, 5 companies have reached yearly highs Continue reading...

  • Motley Fool

    Is Resmed a Buy?

    The CPAP pioneer has a phenomenal track record of success, but should investors jump on board today?

  • Motley Fool

    3 More Medtech Stocks for Your Watch List

    These three companies are pumping fresh air into the lungs of millions all over the world.

  • RMD Stock Wakes Up
    Investor's Business Daily Video

    RMD Stock Wakes Up

    ResMed gapped up out of a downward-sloping flat base, surging on earnings. The maker of sleep apnea products reported better-than-expected earnings growth and the third straight quarter of slowly accelerating revenue growth.

  • ResMed marks 20 years as a public company
    Yahoo Finance Video

    ResMed marks 20 years as a public company

    Mick Farrell, ResMed CEO, joined Yahoo Finance from the New York Stock Exchange as the company celebrates its 20th year as a publicly traded company.